Amgen Inc. is experiencing a notable uptick in its stock price, attributed to positive market sentiment and strong fundamentals.
Amgen Inc. (NASDAQ:AMGN) is rising today, with shares up 1.91% to close at CA$410.30. This increase comes amidst favorable market conditions and strong performance metrics for the biotechnology giant.
Advertisement
Amgen Inc
AMGN.US
AMGN.US
Amgen Inc
WealthAwesomeMarket cap
$223.32B
P/E
25.0x
Div. yield
2.43%
Div. / share
$9.80
52W high
$447.03
52W low
$280.23
1W change
+0.04%
Beta
0.41
Analyst Price Targets
Based on 34 analysts covering AMGN · as of Oct 9, 2026
Wall Street analysts forecast AMGN stock price to fall 3.9% over the next 12 months.
Consensus
Hold3.35 / 5.00
Avg. Target
C$391.46
-3.9% Upside
Previously C$390.94 on Oct 5, 2026
Current Price
C$407.44
Last close
Analyst Breakdown (34 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AMGN's historical volatility
30-Day Vol
40.1%
Annualized
90-Day Vol
32.5%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$487.10
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$432.43 | C$376.50 – C$496.67 |
| 60 trading days | C$458.95 | C$377.31 – C$558.25 |
| 90 trading days | C$487.10 | C$383.21 – C$619.16 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors may find Amgen's current performance encouraging, particularly given its robust profit margins and market capitalization, suggesting a solid investment opportunity.
Amgen's Market Cap Reaches CA$217.9 Billion
With a P/E ratio of 25.01, Amgen's valuation reflects investor confidence in its growth potential, despite recent fluctuations in stock performance.
Bull case
Amgen benefits from economies of scale and impressive free cash flow, positioning the company well for future growth. This strong financial footing allows it to invest in new projects or return value to shareholders through dividends and buybacks.
Bear case
Despite today's gains, Amgen's stock has declined by 7.8% over the past month. This raises concerns about short-term volatility and market positioning as competition in the biotech sector increases.
Strong Financials Support Stock Performance
Advertisement
Amgen's financial health is underscored by a profit margin of 22.95% and a market cap of CA$217.9 billion. These metrics indicate the company's ability to generate substantial profits relative to its revenue, appealing to investors looking for stability in the biotech sector.
Market Sentiment and Future Outlook
The positive movement in Amgen's stock price today can be attributed to renewed investor interest and optimism surrounding the company's innovative pipeline. As the largest biotech drugmaker, Amgen is well-positioned to capitalize on its operational efficiencies and strong cash flow, which could lead to further gains in the near future.
Challenges Ahead Despite Gains
While today's gains are promising, Amgen has faced a 7.8% decline over the past month, highlighting potential volatility. Investors should remain cautious and consider the competitive landscape in the biotech industry as they evaluate their positions in AMGN.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
